Skip to main content

Table 1 Clinical features of the TCGA samples

From: Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation

Characteristics Mutation (N = 235) Wild (N = 274) p value
N % N %
Age 0.005
 ≤ 65 127 54.04 109 39.78  
 > 65 102 43.41 153 55.84  
 NA 6 2.55 12 4.38  
Sex      0.994
 Male 109 46.38 127 46.35  
 Female 126 53.62 147 53.65  
Stage      0.630
 Stage I 120 51.06 155 56.57  
 Stage II 60 25.53 59 21.54  
 Stage III 38 16.17 45 16.42  
 Stage IV 14 5.96 11 4.01  
 NA 3 1.28 4 1.46  
T      0.565
 T1 75 31.91 93 33.94  
 T2 131 55.74 145 52.92  
 T3 19 8.09 25 9.12  
 T4 8 3.40 11 4.01  
 NA 2 0.85 0 0.00  
M      0.190
 M0 150 63.83 195 71.17  
 M1 14 5.96 11 4.01  
 NA 71 30.21 68 24.82  
N      0.384
 N0 146 62.13 180 65.69  
 N1 50 21.28 47 17.15  
 N2 33 14.04 40 14.60  
 N3 2 0.85 0 0.00  
 NA 4 1.70 7 2.55